S'abonner

Influence of weight variation on long-term mortality of patients with heart failure - 02/09/23

Doi : 10.1016/j.acvd.2023.06.007 
Nuno Melo a, Ana I. Ferreira a, Clara Silva a, Diana Oliveira a, João Enes a, Maria J. Lume a, Joana Pereira a, b, c, José P. Araújo b, Patrícia Lourenço a, b,
a Internal Medicine Department, Centro Hospitalar e Universitário de São João, 4200–319 Porto, Portugal 
b Medicine Department, Faculty of Medicine, Porto University, 4200–319 Porto, Portugal 
c Heart Failure Clinic of the Internal Medicine Department, Centro Hospitalar e Universitário de São João, 4200–319 Porto, Portugal 

Corresponding author. Internal Medicine Department, Centro Hospitalar e Universitário de São João, Alameda Prof. Hernâni Monteiro, 4200–319 Porto, Portugal.Internal Medicine Department, Centro Hospitalar e Universitário de São João, Alameda Prof. Hernâni MonteiroPorto4200–319Portugal

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Highlights

Cachexia is associated with poor survival in patients with HF.
Weight loss predicted higher mortality in low/normal-weight patients with HF.
Weight loss also predicted higher mortality in overweight patients with HF.
In obese patients, significant weight loss was not associated with poorer survival.
Weight loss should not be discouraged in obese patients with HF.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

In heart failure, weight loss predicts dismal prognosis. Weight variations have not been addressed in obese patients with heart failure.

Aim

To study the impact of weight variation on heart failure mortality according to body mass index strata.

Methods

Retrospective study of patients with chronic heart failure with left ventricular ejection fraction<50%. Only patients with ≥1 year of follow-up were included. Patients with missing data for body mass index at the index and 1-year appointments were excluded. Patients were classified into three groups according to weight variation: weight gain>5%; weight loss>5%; and weight stability. Follow-up was set from the 1-year appointment. Cox-regression analysis was used to assess the prognostic impact of weight variation.

Results

We studied 589 patients: 69.8% male; mean age, 69 years. Over 1 year, 148 patients (25.1%) gained>5% weight, 97 (16.5%) lost>5% weight and the remaining 344 were weight-stable. During 49 months of median follow-up, 248 patients died. Patients who lost>5% of their weight presented a higher death risk than the others (hazard ratio 1.61, 95% confidence interval 1.18–2.19). After multivariable adjustment, the hazard ratio for death for low/normal-weight patients who lost>5% of their weight was 1.81 (95% confidence interval 1.02–3.21; P=0.04) compared with the others. Among the overweight, those who lost>5% of their weight had a hazard ratio of 2.34 (95% confidence interval 1.32–4.12). In the initially obese subgroup, weight loss>5% was not associated with prognosis (hazard ratio 1.08, 95% confidence interval 0.53–2.19).

Conclusions

Weight loss predicted mortality in low/normal-weight and overweight patients with heart failure. However, in obese patients, significant weight loss did not predict poorer survival. Weight loss should not be discouraged in obese patients with heart failure.

Le texte complet de cet article est disponible en PDF.

Keywords : Heart failure, Body mass index, Obesity paradox, Weight variation, Prognosis


Plan


 Tweet: Weight loss is mortality associated in non-obese HF patients; in obese ones, weight loss >5% is not clearly associated with poor prognosis. Obese HF patients should be further studied concerning weight management strategies. Twitter handle: @nunnomello.


© 2023  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 116 - N° 8-9

P. 403-410 - août 2023 Retour au numéro
Article précédent Article précédent
  • Development and validation of machine learning algorithms to predict posthypertensive origin in left ventricular hypertrophy
  • Maxime Beneyto, Ghada Ghyaza, Eve Cariou, Jacques Amar, Olivier Lairez
| Article suivant Article suivant
  • Is “moderate” aortic stenosis still the right name? A review of the literature
  • Yohann Bohbot, Augustin Coisne, Alexandre Altes, Franck Levy, Chloé Di Lena, Samy Aghezzaf, Sylvestre Maréchaux, Dan Rusinaru, Christophe Tribouilloy

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.